Connect with us
Our website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Research Reports

The Infection prevention Market is projected to rise at a CAGR of 4.2% through 2031

gbaf1news

According to a recent study by Future Market Insights (FMI), sales of infection prevention products are expected to top US$ 37.4 Bn in 2021, at a CAGR of over 4.2% during the forecast period (2021-2031).

Rising cases of infectious diseases caused due to the pathogenic organisms such as bacteria, fungi, viruses and other parasitic organism are improving the adoption of infection preventing products.

As reported by the Centre for Disease Control and Prevention (CDC) in 2018, infectious disease is the third most leading cause of death in the U.S. followed by other infectious diseases such as tuberculosis (9,025 cases), salmonella (60,99 cases), Lyme disease (33,666 cases), meningococcal disease (327 cases) and parasitic diseases (15.5 Mn cases).

Several other factors such as rising incidence of infections acquired while in hospital (often called as Hospital Acquired Infections or HAI), large number of surgical procedures, and increasing cases of chronic diseases among geriatric population have led to higher emphasis on maintaining proper hygiene and cleanliness. 

Sudden outbreak of pandemic increased the number of patients in hospital during the FQ-20, elevating the risk of viral transmission amongst them. This in turn has created the demand for infection preventing and controlling options such as the use of hand sanitizers, disinfectants and other such products.

The Infection prevention Market is projected to rise at a CAGR of 4.2% through 2031 3
Infection prevention Market

Increase in sales of these infection prevention products is expected to boost the infection prevention market growth in near future. The market registered spike in demand for infection preventive products, especially in emerging economies such as India.

As per Future Market Insights, the India infection prevention market registered highest growth across South Asia, reaching US$ 17.29 Bn in 2021. 

Additionally, companies manufacturing infection prevention products have been focusing on developing eco- friendly and sustainable bio-based products with superior efficacy. Drive towards sustainability is expected to strengthen infection prevention market, creating worthwhile opportunities for growth.

Increasing ageing population worldwide has resulted in higher focus on proper hygiene and self-care solutions due to the rise in chronic diseases and onset of COVID-19. Furthermore, increase in consumer spending, improved healthcare infrastructure, rising government and industry investments in research and development activities will create demand for infection prevention product.

Based on the aforementioned factors, Future Market Insights (FMI) estimates that the market is expected to create absolute $ opportunity, exceeding more than US$ 56.39 Bn by 2031-end.

Request The Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-13950

Key Takeaways from Infection Prevention Market Study

  • By product, sterilization equipment is the most lucrative segment in terms of revenue and is anticipated to grow at a CAGR of more than 4.9% during 2021-2031.
  • Based on end-user, hospitals and clinics segment is leading the market and expected to gain more than 42% of revenue share through 2031.
  • The U.S. is expected to dominate the global infection prevention market in terms of revenue in 2021, followed by the U.K. and Germany.
  • India is expected to be the most lucrative market in terms of revenue across South Asia, accounting for over 50% of market value share in 2021.
  • China holds leading position in East Asia and is expected to account for nearly 48% of market share.

“Backed by the unprecedented outbreak of COVID-19, demand for infection preventing products is increasing. Key players are introducing products made from sustainable and eco-friendly materials to gain competitive edge,” says the FMI Analyst.

Who is Winning?

Some of the leading manufacturers of infection prevention products are focusing on new product development, clinical trials, speedy regulatory approvals, exclusive marketing and distribution licensing agreement strategies, thereby enhancing their market presence.

  • In 2021, a new 3M™ Clean & Protect Certified Badge Program was launched by 3M company. A new comprehensive system designed for effective cleaning and disinfecting solution that cleans, monitors and protects the facilities.
  • In July 2020, Reckitt Benckiser Group PLC in partnership with water.org made provisions for improved access to safe, clean water in Kenya. In the same month, the company received the EPA approval for the first surface disinfectant products tested on the SARS-COV-2 virus.
  • In 2021, Metrex collaborated with Solvay for chemical resistance testing of widely-used disinfectants in healthcare settings.

The key market players covered by FMI include Cantel Medical, Getinge AB, STERIS, ASP (Advanced sterilization Products), Sotera Health, 3M, Ecolab, Halyard Worldwide, Inc. (Halyard health), Matachana Group, Belimed, Inc., Pal International, Reckitt Benckiser Group PLC., Metrex Research, LLC., Terumo Corporation, Ahlstrom Munksjo and Ansell Ltd.

Speak To Analyst about queries @ https://www.futuremarketinsights.com/ask-question/rep-gb-13950

Table of Content

  1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

  1. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

  1. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Drug Development Trends

  1. Market Background

    4.1. Macro-Economic Factors

        4.1.1. Global Healthcare Industry Outlook 

        4.1.2. COVID-19 Outbreak: Short-term Benefits for Disinfectant Chemical Companies

        4.1.3. Steady Growth in Specialty Chemicals Industry to Boost Market Growth

    4.2. Forecast Factors – Relevance & Impact

        4.2.1. Incidence of Infection 

        4.2.2. Regulatory Imposition on Infection Prevention Products

        4.2.3. Infection Prevention Products Pipeline Assessment

        4.2.4. Incremental R&D by Product-Based Companies 

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities 

  1. Market Context

    5.1. Product Adoption / Usage Analysis

    5.2. Product USPs / Features

    5.3. Strategic Promotional Strategies, By Key Manufacturers

    5.4. Infection Prevention Products adoption, By Region

    5.5. Key Regulations, By Region

  1. COVID19 Crisis Analysis

    6.1. Current COVID19 Statistics and Probable Future Impact

    6.2. Current GDP Projection and Probable Impact

    6.3. COVID19 and Impact Analysis

    6.4. 2020 Market Scenario

    6.5. Recovery Scenario – Short term, Midterm and Long Term Impact

  1. Global Infection Prevention Products and Services Market – Pricing Analysis

The post The Infection prevention Market is projected to rise at a CAGR of 4.2% through 2031 appeared first on Market Research Blog.

Global Banking and Finance Review Awards Nominations 2022
2022 Awards now open. Click Here to Nominate

Advertisement

Newsletters with Secrets & Analysis. Subscribe Now